New therapy for blood cancers using drug combo

Thursday, June 2, 2011 - 16:30 in Health & Medicine

Clinical researchers have successfully completed a Phase I clinical trial evaluating a combination of the drugs bortezomib and alvocidib in patients with relapsed or refractory blood cancers, paving the way for a Phase II clinical trial to test the safety and effectiveness of the new therapy.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net